chrX-153872575-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001278116.2(L1CAM):c.197+17G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00545 in 1,150,122 control chromosomes in the GnomAD database, including 162 homozygotes. There are 1,650 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.024 ( 76 hom., 666 hem., cov: 23)
Exomes 𝑓: 0.0035 ( 86 hom. 984 hem. )
Consequence
L1CAM
NM_001278116.2 intron
NM_001278116.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.202
Publications
1 publications found
Genes affected
L1CAM (HGNC:6470): (L1 cell adhesion molecule) The protein encoded by this gene is an axonal glycoprotein belonging to the immunoglobulin supergene family. The ectodomain, consisting of several immunoglobulin-like domains and fibronectin-like repeats (type III), is linked via a single transmembrane sequence to a conserved cytoplasmic domain. This cell adhesion molecule plays an important role in nervous system development, including neuronal migration and differentiation. Mutations in the gene cause X-linked neurological syndromes known as CRASH (corpus callosum hypoplasia, retardation, aphasia, spastic paraplegia and hydrocephalus). Alternative splicing of this gene results in multiple transcript variants, some of which include an alternate exon that is considered to be specific to neurons. [provided by RefSeq, May 2013]
L1CAM Gene-Disease associations (from GenCC):
- L1 syndromeInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- X-linked hydrocephalus with stenosis of the aqueduct of SylviusInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
- MASA syndromeInheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
- X-linked complicated corpus callosum dysgenesisInheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- X-linked complicated spastic paraplegia type 1Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant X-153872575-C-T is Benign according to our data. Variant chrX-153872575-C-T is described in ClinVar as Benign. ClinVar VariationId is 92921.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0766 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| L1CAM | NM_001278116.2 | c.197+17G>A | intron_variant | Intron 4 of 28 | ENST00000370060.7 | NP_001265045.1 | ||
| L1CAM | NM_000425.5 | c.197+17G>A | intron_variant | Intron 3 of 27 | NP_000416.1 | |||
| L1CAM | NM_024003.3 | c.197+17G>A | intron_variant | Intron 3 of 26 | NP_076493.1 | |||
| L1CAM | NM_001143963.2 | c.182+17G>A | intron_variant | Intron 2 of 25 | NP_001137435.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0237 AC: 2636AN: 111073Hom.: 75 Cov.: 23 show subpopulations
GnomAD3 genomes
AF:
AC:
2636
AN:
111073
Hom.:
Cov.:
23
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00748 AC: 1367AN: 182710 AF XY: 0.00504 show subpopulations
GnomAD2 exomes
AF:
AC:
1367
AN:
182710
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00349 AC: 3621AN: 1038991Hom.: 86 Cov.: 26 AF XY: 0.00308 AC XY: 984AN XY: 319661 show subpopulations
GnomAD4 exome
AF:
AC:
3621
AN:
1038991
Hom.:
Cov.:
26
AF XY:
AC XY:
984
AN XY:
319661
show subpopulations
African (AFR)
AF:
AC:
2002
AN:
25316
American (AMR)
AF:
AC:
174
AN:
35130
Ashkenazi Jewish (ASJ)
AF:
AC:
163
AN:
19008
East Asian (EAS)
AF:
AC:
5
AN:
29988
South Asian (SAS)
AF:
AC:
15
AN:
52824
European-Finnish (FIN)
AF:
AC:
5
AN:
40464
Middle Eastern (MID)
AF:
AC:
15
AN:
4005
European-Non Finnish (NFE)
AF:
AC:
936
AN:
788069
Other (OTH)
AF:
AC:
306
AN:
44187
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
135
270
405
540
675
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0239 AC: 2651AN: 111131Hom.: 76 Cov.: 23 AF XY: 0.0200 AC XY: 666AN XY: 33367 show subpopulations
GnomAD4 genome
AF:
AC:
2651
AN:
111131
Hom.:
Cov.:
23
AF XY:
AC XY:
666
AN XY:
33367
show subpopulations
African (AFR)
AF:
AC:
2420
AN:
30560
American (AMR)
AF:
AC:
90
AN:
10474
Ashkenazi Jewish (ASJ)
AF:
AC:
20
AN:
2642
East Asian (EAS)
AF:
AC:
0
AN:
3495
South Asian (SAS)
AF:
AC:
1
AN:
2555
European-Finnish (FIN)
AF:
AC:
1
AN:
6065
Middle Eastern (MID)
AF:
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
AC:
82
AN:
52944
Other (OTH)
AF:
AC:
37
AN:
1496
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
88
176
263
351
439
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Jul 01, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Aug 01, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Spastic paraplegia Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.